Benifaziri和Ruzaziri联合疗法

Search documents
Atea Pharmaceuticals(AVIR) - 2025 Q2 - Earnings Call Transcript
2025-08-07 21:30
Atea Pharmaceuticals (AVIR) Q2 2025 Earnings Call August 07, 2025 04:30 PM ET Speaker0Good afternoon, and welcome to the Atea Pharmaceuticals Second Quarter twenty twenty five Earnings Conference Call. All participants will be in listen only mode. Please note this event is being recorded. I would now like to turn the conference over to Janae Barnes, Senior Vice President, Investor Relations and Corporate Communications. Please go ahead.Speaker1Great. Thank you, and good afternoon, everyone, and welcome to A ...